Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhBNP in sepsis complicated with heart failure
NCT05111769Unknown
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Dec 2021
- Primary completion
- Dec 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised trial of nesiritide in sepsis and heart failure (HF) (2 arms), sponsored by Zhongshan Hospital, Fudan University. Primary endpoints: Effects of rhBNP on cardiac function at 72 hours and PiCCO hemodynamic monitoring at 72 hours. Status: unknown.
02
Drugs
nesiritide
03
Conditions
sepsisheart failure (HF)
Beyond the preview
Go deeper on NCT05111769.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05111769.